Papillary Recurrence of Bladder Cancer at First Evaluation after Induction Bacillus Calmette-Guérin Therapy: Implication for Clinical Trial Design

BACKGROUND: Recurrence with papillary tumor(s) by 3-mo after induction bacillus Calmette-Guérin (BCG) is historically believed to be a poor prognostic indicator in patients with high-risk nonmuscle invasive bladder cancer. However, the impact of a clinical Ta (cTa) papillary recurrence at 3 mo after...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Eur Urol
Hlavní autoři: Mmeje, Chinedu O., Guo, Charles C., Shah, Jay B., Navai, Neema, Grossman, H. Barton, Dinney, Colin P., Kamat, Ashish M.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2016
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5115993/
https://ncbi.nlm.nih.gov/pubmed/26922408
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2016.02.031
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky